<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BagolieFriedman.com</title>
	<atom:link href="http://www.bagoliefriedman.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bagoliefriedman.com</link>
	<description></description>
	<lastBuildDate>Tue, 21 Feb 2012 18:22:49 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Damage Caused by Pain Pumps</title>
		<link>http://www.bagoliefriedman.com/2011/09/damage-caused-by-pain-pumps/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/damage-caused-by-pain-pumps/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 19:27:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Product Liability]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=666</guid>
		<description><![CDATA[Recent studies have identified intra-articular pain pumps as a likely cause of severe cartilage damage, primarily in the shoulder but possibly in other joints as well. In the shoulder, this condition is known as Postarthroscopic Glenohumeral Chrondrolysis (PAGCL). This is &#8230; <a href="http://www.bagoliefriedman.com/2011/09/damage-caused-by-pain-pumps/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p>Recent studies have identified intra-articular pain pumps as a likely cause of severe cartilage damage, primarily in the shoulder but possibly in other joints as well. In the shoulder, this condition is known as Postarthroscopic Glenohumeral Chrondrolysis (PAGCL). This is a devastating condition that causes severe pain and the need for constant medication. The condition may ultimately require shoulder joint replacement surgery.</p>
<p class="subhead">How Pain Pumps are Involved</p>
<p>In a recent edition of the American Journal of Sports Medicine, researchers have identified high-flow intra-articular pain pumps as the likely cause of PAGCL. Other studies are currently underway to confirm these findings.</p>
<p class="subhead">My Next Step</p>
<p>If you or a loved one have been injured by an intra-articular pain pump, or if you, a family member or friend have the symptoms or diagnosis of PAGCL, you may have important valuable legal rights. If you would like to discuss a potential case please feel free to call toll free <STRONG>1-866-333-3LAW</STRONG> (1-866-333-3529)or submit a <A href="contact-us" target="_self">FREE online case review</A> .(1-888-241-0112) for a free, no-cost no-obligation evaluation of your case.</p>
<p>Implanted in to the shoulder joint during surgery, intra-articular pain pumps are becoming more commonly used in the medical field as a solution to pain management. The pain pumps have been recently linked to a very painful condition called Post-arthroscopic Glenohumeral Chondrolysis (PAGCL).</p>
<p>Arthroscopic surgery was designed to be less invasive of the human body, it consists of two small incisions, one for surgical tools, and the other for a camera to view the surgery site. Not only is recovery time faster, but the body is open to fewer complications without an open surgery site.</p>
<p>Pain pumps work up to 72 hours following an arthroscopic surgical procedure of the shoulder. It is a disposable pump that delivers pain medication directly to the surgery site. This direct method of pain relief negates the negative side effects that are often felt after surgery with the uses of various narcotics and pain killers.</p>
<p class="subhead">PAGCL Condition</p>
<p>PAGCL is the severe damage of the cartilage of the shoulder. Believed to be linked to the high dosages of numbing medications that are heavily administered following the procedure, the damage caused is thought to be irreversible. Additionally, the only solution to PAGCL as of yet is to have shoulder replacement surgery. Medications that assist with pain are believed only to worsen the symptoms and possess not long term value in regard treatment or cure. PAGCL begins to develop as early as 2 months after surgery, up until a year following the arthroscopic procedure.</p>
<p class="subhead">Brand Names of Shoulder Pumps.</p>
<p>These pumps can be found under brand names such as the <STRONG>Stryker Pain Pump</STRONG>, in addition to the<STRONG> I-Flow On-Q Pump</STRONG>. These manufacturers are under heavy scrutiny from the medical world, as well as thousands of affected patients.</p>
<p>Take a stand against those who thrive financially at your expense. Seek the compensation you are due for the pain and suffering you and your family have endured. Fill out a free case review form to the right of the page and our legal intake specialists will contact you. Steigerwalt  and Associates prides itself on diligence and confidentiality and seeks to help you in your time of need.</p>
<p>A study published in the American Journal of Sports Medicine revealed that the use of intra-articular pain pump catheters after shoulder surgery appears to cause permanent cartilage damage. The condition, which is known as postarthroscopic glenohumeral chondrolysis or PAGCL is a life altering condition that is extremely painful and affects the use of the shoulder. An intra-articular pain pump catheter is a tiny, flexible plastic tube that is implanted in the shoulder joint during surgery. The pain pump stays in place for several days after surgery to deliver pain medication, usually bupivacaine with epinephrine) to the shoulder joint. </p>
<p class="subhead">Arthroscopic Shoulder Surgery</p>
<p>Intra-articular pain pump catheters are now commonly used after arthroscopic shoulder surgeries. This type of surgery uses a tiny camera and allows surgeons to perform the surgery by making two tiny incisions. One incision is made for the camera and the other for the surgical instruments. The surgeon performs the surgery by viewing images on a monitor attached to the camera. </p>
<p class="subhead">Intra-Articular Pain Pumps</p>
<p>Post surgery, patients who underwent arthroscopic shoulder usually requires a regime of medication to manage their pain. Oral painkillers such as codeine and morphine are often prescribed, as well as anti-inflammatory drugs including ibuprofen and cox II inhibitors. However, these oral medications are often not enough to manage the post-surgical pain of arthroscopic shoulder surgery. To better manage the pain, a disposable pain pump is often used to pump pain medication directly into the shoulder joint through a catheter. The pain pump is typically used for the first two to three days after surgery and is removed directly by the patient. </p>
<p class="subhead">Postarthroscopic Glenohumeral Chondrolysis</p>
<p>New studies have revealed the use of the intra-articular pain pumps after shoulder can cause Postarthroscopic Glenohumeral Chondrolysis or PAGCL. This may occur because the concentration of pain medication pumped directly into the shoulder is too high. </p>
<p>Postarthroscopic Glenohumeral Chondrolysis destroys cartilage of the glenohumeral joint, the joint that joins the arm and shoulder. The head of the arm bone, which connects to the joint, is covered in articular cartilage, which allows the shoulder joint to move smoothly.</p>
<p> If this cartilage is damaged or destroyed the shoulder cannot move easily resulting in significant pain and reduced range of motion. If you&rsquo;ve had arthroscopic shoulder surgery and are experiencing any of the following symptoms you should contact your doctor immediately:</p>
<ul type="circle">
<li>Continued shoulder pain</li>
<p><BR></p>
<li>Decreased range of motion</li>
<p><BR></p>
<li>Clicking, popping, or grinding</li>
<p></p>
<li>Shoulder weakness</li>
</ul>
<p class="subhead">What Should I Do?</p>
<p>Have you or a loved one had should surgery and have been diagnosed with Postarthroscopic Glenohumeral Chondrolysis?&nbsp; &nbsp;Trust Bagolie Friedman Injury Lawyers to fight for your rights and obtain the justice you deserve. We offer aggressive representation and free consultations. We are personal injury and workers&#8217; compensation trial lawyers.</p>
<p>Contact us now for a free, confidential and no risk consultation if you have questions about any type of accident, injury, disability, workers&#8217; compensation or disease claim. Whatever legal problem you have, our personal injury attorneys want to help.</p>
<p>This resource offers information on a wide variety of personal injury case types and is intended to help injury victims find the information they need to understand their legal rights and make informed decisions. If you would like to discuss a potential case please feel free to call toll free <STRONG>1-866-333-3LAW</STRONG> (1-866-333-3529)or submit a <A href="contact-us" target="_self">FREE online case review</A>.</p>
<p><?php<br />
 if (!isset($_POST['Verify'])) {//checks to see if form is submitted, if not, display form<br />
 ?></p>
<hr />
<p class="head">Filing a PAGCL Legal Claim</p>
<p>Please fill out the field below and we will contact you for your FREE CASE REVIEW</p>
<p>
Note that information marked with a red asterisk (<font color=red>*</font>) is<br />
required.</p>
<form name="ContactForm" action="" method="post">
<div class="subhead"><font color="FF0000">*</font> Your Name</div>
<input type="Text" name="Name" size="30">
<div class="subhead"><font color="FF0000">*</font> Your E-mail Address</div>
<input type="Text" name="email" size="30">
<div class="subhead"><font color="FF0000"><br />
    </font>Your Phone Number</div>
<input type="Text" name="Phone" size="30"></p>
<div class="subhead"><font color="FF0000"><br />
    </font>Date of Surgery</div>
<input type="Text" name="date of surgery" size="30"></p>
<div class="subhead"><font color="FF0000"><br />
    </font>Type of Surgery</div>
<input type="Text" name="type of surgery" size="30">
<div class="subhead">
    <font color="FF0000">*</font> Any Comments, Questions or Suggestions</div>
<p>  <textarea name="Comments" cols="30" rows="5"></textarea></p>
<div class="subhead">Was Pain Pump used, either before or after Surgery
</div>
<table border=0 cellpadding=0 cellspacing=0>
<tr>
<td>
<input type="radio" name="Before or After Surgery" value="Yes"> </td>
<td>
<div class="content">Yes</div>
</td>
</tr>
<tr>
<td>
<input type="radio" name="Before or After Surgery" value="No"> </td>
<td>
<div class="content">No</div>
</td>
</tr>
</table>
<div class="subhead">Have you been diagnosed with or have symptoms of PAGCL?</p>
</div>
<table border=0 cellpadding=0 cellspacing=0>
<tr>
<td>
<input type="radio" name="symptoms" value="Yes"> </td>
<td>
<div class="content">Yes</div>
</td>
</tr>
<tr>
<td>
<input type="radio" name="symptoms" value="No"> </td>
<td>
<div class="content">No</div>
</td>
</tr>
<p>					 <!--<br />
<tr style="display:none">
<td class="content">&nbsp;</td>
<td align="center">
<input name="Verify" type="text" class="contactbox" id="Verify">
                        </td>
</tr>
<p>&#8212;><br />
  </table>
<p>
<input type="button" onClick="submitContactForm();" value="Send Message" class="sendbutton">
      </form>
<p><?php<br />
} else {<br />
//CONFIG AREA<br />
$website = "BAGOLIE FRIEDMAN, LLC"; //The name you want displayed where ever the script requires it<br />
$subject = "PAGCL Legal Claim";//what will show in the subject line of the email, do not put the business name here<br />
$recipient = "info@bagoliefriedman.com"; //Who the email is going to, separate multiple emails with a comma<br />
$recipient_cc = ""; //Who the email is going to, carbon copy<br />
$recipient_bcc = ""; //Who the email is going to, blind carbon copy<br />
$format = "html";//change to "text" if needed<br />
//END CONFIG AREA<br />
$email = $_POST['email'];<br />
$name = $_POST['Name'];<br />
$subject = $website.' '.$subject;</p>
<p>if (!empty($_POST['Verify'])) {//checks to see if this form was submitted by a spam bot<br />
     exit("{$_SERVER['REMOTE_ADDR']} Has been Recorded");<br />
}<br />
;<br />
if(gethostbyaddr($_SERVER['REMOTE_ADDR']) == $_SERVER['REMOTE_ADDR']) {<br />
	exit("{$_SERVER['REMOTE_ADDR']} Has been Recorded");}</p>
<p>foreach($_POST as $field => $input) {<br />
  $input = stripslashes($input);<br />
   	if(preg_match(&#8220;/(http:)/i&#8221;, $input))  $attack++;<br />
  	if(preg_match(&#8220;/(%0A|%0D|\n+|\r+)(content-type:|to:|cc:|bcc:)/i&#8221;, $input))  $attack++;<br />
}<br />
if($attack)  {<br />
     exit(&#8220;{$_SERVER['REMOTE_ADDR']} Has been Recorded&#8221;);<br />
}<br />
//if ok, process form<br />
$emailcheck = $_POST['email'];<br />
if (!eregi(&#8220;^[_a-z0-9-]+(.[_a-z0-9-]+)*@[a-z0-9-]+(.[a-z0-9-]+)*(.[a-z]{2,3})$&#8221;, $emailcheck)) {<br />
			print &#8220;
<p>The email address you entered is not valid.</p>
<p>Please return and enter a valid email address before submitting. <a href='javascript: history.go(-1)'>Back to form</a>.</p>
<p>&#8220;;<br />
			include (&#8220;footer.html&#8221;);<br />
			exit;<br />
}</p>
<p>$htmlFormat = (strtolower(substr($format,0,1)) == &#8216;h&#8217;);</p>
<p>$msg = &#8221;;<br />
if($htmlFormat) {<br />
	$msg = &#8220;<html><head><br />
<style>td {font: x-small, verdana, arial, helvetica, sans-serif;} .fldname {font-weight:bold;font-size:x-small;} .flddata {font-size:x-small;} .tblhdr { font-size:x-small;font-weight:bold;color:#FFFFFF;background-color=#000000}</style>
<p></head><body>\n&#8221;;<br />
	$msg .= &#8220;<br />
<table border=0 cellspacing=0 cellpadding=5 width=640>\n&#8221;;<br />
	$msg .= &#8220;<br />
<tr>
<td colspan=3 class='tblhdr'>&#8220;.$website.&#8221; Form Information</td>
</tr>
<p>\n&#8221;;<br />
} else {<br />
	$msg = $website.&#8221; Form Information\n\n&#8221;;<br />
}</p>
<p>$bl0 = &#8221;;<br />
$bl1 = &#8221;;<br />
$ld = &#8216; &#8216;;<br />
$el = &#8220;\n\n&#8221;;</p>
<p>$creditStrAdd = &#8221;;</p>
<p>if($htmlFormat) {<br />
	$bl0 = &#8216;<br />
<tr bgcolor=#f1f2f2>
<td class="fldname" valign=top>&#8216;;<br />
	$bl1 = &#8216;<br />
<tr bgcolor=#FFFFFF>
<td class="fldname" valign=top>&#8216;;<br />
	$ld = &#8216;</td>
<td> &nbsp; </td>
<td width=80% class="flddata">&#8216;;<br />
	$el = &#8220;</td>
</tr>
<p>\n&#8221;;<br />
}<br />
$i = 0;<br />
foreach($_POST as $k => $v) {<br />
if(!empty($v)){<br />
	if($htmlFormat) {<br />
		$v = str_replace(&#8220;\n&#8221;,&#8221;<br />\n&#8221;,$v);<br />
	}<br />
	if($i) {<br />
		$msg .= &#8220;$bl0$k:$ld$v$el&#8221;;<br />
	} else {<br />
		$msg .= &#8220;$bl1$k:$ld$v$el&#8221;;<br />
	}<br />
	$i = !$i;<br />
}<br />
}<br />
if($htmlFormat) {<br />
	$msg .= &#8220;<br />
<tr>
<td colspan=3>&nbsp;</td>
</tr>
<tr>
<td colspan=3 align=right>Generated by MegaHunter Forms$creditStrAdd
<td></tr>
</table>
<p></body></html>\n&#8221;;<br />
} else {<br />
	$msg .= &#8220;\n\nGenerated by MegaHunter Forms$creditStrAdd\n&#8221;;<br />
}</p>
<p>$extraHeaders = &#8220;&#8221;;<br />
ini_set (&#8220;sendmail_from&#8221;,&#8221;info@bagoliefriedman.com&#8221;);<br />
$extraHeaders .= &#8220;From: $name\r\n&#8221;;<br />
if($email != &#8221;) { $extraHeaders .= &#8220;Reply-To: $email\r\n&#8221;; }<br />
if($htmlFormat == &#8216;h&#8217;) { $extraHeaders .= &#8220;Content-type: text/html\r\n&#8221;; }<br />
if($recipient_cc != &#8221;) { $extraHeaders .= &#8220;Cc: $recipient_cc\r\n&#8221;; }<br />
if($recipient_bcc != &#8221;) { $extraHeaders .= &#8220;Bcc: $recipient_bcc\r\n&#8221;; }</p>
<p>$success = 1;<br />
$success = mail($recipient,$subject,$msg,$extraHeaders);</p>
<p>echo (&#8220;<br />
<h1>Thank You!</h1>
<p>Your message has been delivered to <b>&#8220;.$website.&#8221;</b>.  We will respond to you as soon as possible.&#8221;);//if delivered, give success message<br />
}</p>
<p>?> </p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/damage-caused-by-pain-pumps/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lariam Lawsuits</title>
		<link>http://www.bagoliefriedman.com/2011/09/lariam-lawsuits/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/lariam-lawsuits/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 19:15:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Product Liability]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=662</guid>
		<description><![CDATA[Lariam (generic name: mefloquine hydrochloride) has been linked to serious psychiatric side effects including suicide, aggression and long term mental problems. Lariam is a popular malaria prevention drug prescribed to thousands of U.S. travelers and military personnel as well as &#8230; <a href="http://www.bagoliefriedman.com/2011/09/lariam-lawsuits/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p>Lariam (generic name: mefloquine hydrochloride) has been linked to serious psychiatric side effects including suicide, aggression and long term mental problems. Lariam is a popular malaria prevention drug prescribed to thousands of U.S. travelers and military personnel as well as soldiers in Australia and the UK. </p>
<p>Roche, the manufacturer of Lariam, has sent notices to doctors and other health-care professionals warning of the risk of suicide. The warnings come after new questions were raised about Lariam after army investigators said that they would examine whether the drug was one factor in a series of widely publicized murders and suicides by soldiers this summer in Fort Bragg, N.C.</p>
<p>Roche changed the drug&#8217;s label and official product information to acknowledge &quot;rare cases of suicidal ideation and suicide have been reported.&quot; Now it plans to publicize the move by sending written notices to thousands of doctors around the U.S.</p>
<p>&quot;If symptoms of acute anxiety, depression and confusion occur,&quot; the new label says, they could lead &quot;to a more serious event.&quot; In such case, patients should quit the drug and take another malaria medicine.</p>
<p>Lariam, which has been prescribed to 25 million people world-wide since its introduction in 1985, is one of the most effective prevention treatments for malaria, one of the world&#8217;s most deadly infectious diseases.</p>
<p>The U.S. Centers for Disease Control and Prevention recommends Lariam as the drug standard in 79 countries where malaria is resistant to other drugs. Developed by the U.S. army and later licensed to Roche, the drug was first tested and used primarily among the military. But it has grown popular with many U.S. tourists to increasingly trendy Third World destinations, as well as with Peace Corps volunteers and aid workers.</p>
<p class="head">Free Case Review!</p>
<p><a href="contact-us">Click here</a> for a free Lariam case review.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/lariam-lawsuits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Possible Class Action Lawsuit against Vioxx</title>
		<link>http://www.bagoliefriedman.com/2011/09/possible-class-action-lawsuit-against-vioxx/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/possible-class-action-lawsuit-against-vioxx/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 19:10:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Product Liability]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=658</guid>
		<description><![CDATA[Vioxx (Rofecoxib) is a Cox-2 inhibitor that was approved by the US Food and Drug Administration in 1999 for the treatment of arthritis, osteoarthritis, menstrual pain and for the management of acute pain in adults. Serious concerns have been raised &#8230; <a href="http://www.bagoliefriedman.com/2011/09/possible-class-action-lawsuit-against-vioxx/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p> Vioxx (Rofecoxib) is a Cox-2 inhibitor that was approved by the US Food and Drug Administration in 1999 for the treatment of arthritis, osteoarthritis, menstrual pain and for the management of acute pain in adults. Serious concerns have been raised in recent months regarding the use of Vioxx, Vioxx side effects on kidney and cardiovascular health, and the increased risk of heart attack and stroke. </p>
<p>Vioxx is an anti-inflammatory drug, which means it reduces internal inflammation.  Vioxx, along with Aspirin, is part of the class of drugs known as nonsteroidal anti-inflammatory drugs (NSAID) &#8211; i.e. it is not a steroid. Vioxx is analgesic, (it eliminates pain) and it is antipyretic (it reduces fevers). Its active ingredient is rofecoxib.</p>
<p class="subhead"> Vioxx withdrawn from the market</p>
<p> Vioxx was pulled off the shelves worldwide on September 30th after a clinical study confirmed concerns that it raises the risk of heart attack and stroke, which can lead to serious and permanent injuries and death. More than 2 million people worldwide are using Vioxx.</p>
<p>Complications begin approximately 18 months after patients start taking Vioxx. Previous clinical trials had linked Vioxx to an increase in blood clots and other cardiovascular problems, including heart attack, chest pain related to heart disease, stroke and sudden death. Vioxx users were more than twice as likely to experience heart problems than patients using the control drug.</p>
<p>The results of clinical studies with one drug in a given class do not necessarily apply to other drugs in the same class. All NSAIDs have some risks, such as gastrointestinal (stomach) bleeding, and liver and kidney toxicity, when taken chronically. </p>
<p class="subhead"> Vioxx advisory from FDA</p>
<p> Doctors are being told to take patients off Vioxx. Please talk to your Doctor as soon as possible about switching to another drug. The FDA has issued a public health advisory, and plans to work closely with Merck to coordinate the withdrawal of Vioxx from the US market. </p>
<p>For further information, and to receive a refund on the Vioxx you have purchased, please go to <a href="http://www.vioxx.com" target="_blank">http://www.vioxx.com</a>.</p>
<p class="subhead">Vioxx Class Action Inquiry</p>
<p>Bagolie Friedman is also investigating claims caused by Bextra, another Cox-II inhibitor manufactured by Pfizer. Bextra causes the same problems as Vioxx. If you or a loved one have suffered heart attack or stroke, or if a loved one has died while taking Vioxx or Bextra, please contact us today!</p>
<p class="head">Free Case Review!</p>
<p><a href="http://www.bagoliefriedman.com/contact-us">Click here</a> for a free Vioxx / Bextra case review. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/possible-class-action-lawsuit-against-vioxx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Complete Moisture Plus Recall Eye Infection Contact Lens Lawsuits</title>
		<link>http://www.bagoliefriedman.com/2011/09/complete-moisture-plus-recall-eye-infection-contact-lens-lawsuits/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/complete-moisture-plus-recall-eye-infection-contact-lens-lawsuits/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 19:05:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Product Liability]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=652</guid>
		<description><![CDATA[Complete Moisture PLUS is an &#8220;all-in-one&#8221; multi-purpose contact lens solution which is manufactured by Advanced Medical Optics (AMO). The company issued a contact solution recall on May 26, 2007 after an alarmingly high number of reported cases of an otherwise &#8230; <a href="http://www.bagoliefriedman.com/2011/09/complete-moisture-plus-recall-eye-infection-contact-lens-lawsuits/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.bagoliefriedman.com/wp/wp-content/uploads/2011/09/con_lens.jpg" alt="" title="" width="157" height="200" class="alignright size-full wp-image-653" />Complete Moisture PLUS is an &#8220;all-in-one&#8221; multi-purpose contact lens solution which is manufactured by Advanced Medical Optics (AMO). The company issued a contact solution recall on May 26, 2007 after an alarmingly high number of reported cases of an otherwise rare and very serious eye infection.</p>
<p>Have you or someone you love been suffering from a severe eye infection or have been diagnosed with Acanthamoeba keratitis, cornea damage or blindness? Trust Bagolie Friedman Injury Lawyers to fight for your rights and obtain the justice you deserve. We offer aggressive representation and free consultations and are currently investigating claims locally, nationally and from around the world.</p>
<p>Over the past three years, eye care centers throughout the United States have been tracking an increased number of Acanthamoeba keratitis infections. The exact number of cases is not yet known, but researchers identified that there is a statistically significant increased risk associated this particular solution, which has approximately 10% of the market share in the United States.</p>
<p class="head">Acanthamoeba Keratitis Eys Infections</p>
<p>Acanthamoeba is a naturally occurring micro-organism which is<br />
  found in water, soil, sewage, cooling towers and HVAC systems (heating and air conditioning). In the past, Acanthamoeba keratitis has been found in about one or two out of every one million contact lens wearers. It is often associated  with users who do not properly clean their lenses or wear their contacts in a pool, hot tub or shower. The U.S. Centers for Disease Control and Prevention (CDC) has indicated that the risk of developing Acanthamoeba keratitis is at least seven (7) times greater for users of Complete MoisturePLUS.</p>
<p><img src="http://www.bagoliefriedman.com/wp/wp-content/uploads/2011/09/eye_brown.jpg" alt="" title="" width="150" height="136" class="alignright size-full wp-image-654" />Treatment of Acanthamoeba keratitis is difficult, so it is important to diagnose the condition early to prevent permanent eye damage. Symptoms are similar to other common eye infections and can effect people differently. Some of the common Acanthamoeba keratitis symptoms include:</p>
<p>&middot; Eye Pain <BR><br />
  &middot; Red Eyes <BR><br />
  &middot; Blurred Vision <BR><br />
  &middot; Sensitivity to Light <BR><br />
  &middot; Feeling that something is in the eye <BR><br />
  &middot; Excessive Tearing <BR></p>
<p>The FDA has advised consumers to stop using the recalled contact lens solution and to replace the actual lenses and storage containers they have been using.</p>
<p><u><strong>Although the FDA has recommended that any unused bottles be discarded, if a serious eye infection has been suffered after using the product and you intend to pursue a lawsuit the remainder should be safely stored and properly marked to avoid future use while you investigate your potential claim.</strong></u></p>
<p class="head">Contact Lens Recall Lawsuits</p>
<p>Have you or someone you love been suffering from a severe eye infection or have been diagnosed with Acanthamoeba Keratitis, cornea damage or blindness? Trust Bagolie Friedman Injury Lawyers to fight for your rights and obtain the justice you deserve. We offer aggressive representation and free consultations.</p>
<p>We are personal injury and workers&#8217; compensation trial lawyers. Contact us now for a free, confidential and no risk consultation if you have questions about any type of accident, injury, disability, workers&#8217; compensation or disease claim. Whatever legal problem you have, our personal injury attorneys want to help. This resource offers information on a wide variety of personal injury case types and is intended to help injury victims find the information they need to understand their legal rights and make informed decisions. If you would like to discuss a potential case please feel free to call toll free <strong>1-866-333-3LAW (1-866-333-3529 )</strong>or <a href="contact-us" target="_self">submit a FREE online case review</a>. </p>
<p class="style1">Trademark Notice<br /> <br />
AMO contact lens solution is a registered trademark of Advanced Medical Optics, Inc. Bagolie Friedman Injury Lawyers is in no way affiliated with Advanced Medical Optics, Inc. All trademarks, service marks, trade names, trade dress and products named in this site are used only to identify products for informational purposes only.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/complete-moisture-plus-recall-eye-infection-contact-lens-lawsuits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ortho Evra Patch Litigation</title>
		<link>http://www.bagoliefriedman.com/2011/09/ortho-evra-patch-litigation/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/ortho-evra-patch-litigation/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 18:56:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Product Liability]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=647</guid>
		<description><![CDATA[Johnson &#38; Johnson&#8217;s Ortho Evra contraceptive patch contains higher levels of a hormone known to cause blood clots than average birth control pills, U.S. regulators warned. The U.S. Food and Drug Administration said on November 10, 2005 that the new &#8230; <a href="http://www.bagoliefriedman.com/2011/09/ortho-evra-patch-litigation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.bagoliefriedman.com/wp/wp-content/uploads/2011/09/orthoevra.jpg" alt="" title="" width="150" height="153" class="alignright size-full wp-image-648" />Johnson &amp; Johnson&#8217;s Ortho Evra contraceptive patch contains higher levels of a hormone known to cause blood clots than average birth control pills, U.S. regulators warned. The U.S. Food and Drug Administration said on November 10, 2005 that the new label for the patch will include information about the higher levels of estrogen. Women who use Ortho Evra are exposed to 60 percent more estrogen than those who use the pill, the FDA said in its statement. But the pills, which contain several variations with different hormone levels for use during one month, can contain a higher maximum amount of estrogen. The difference in exposure may be due to the delivery mechanism of the patch hormones and absorption into the body.</p>
<p>The Food and Drug Administration has received twenty-one reports of life-threatening blood clots and other ailments associated with Ortho Evra birth control patch use. The contraceptive patch, which has been aggressively marketed using Olympic athletes, sexy ads and fashion models, has been linked to the deaths of at least seventeen young American women over the past two years. Approximately 4 million women have used the Ortho Evra Patch since it went on sale in 2002. FDA records show that seventeen patch users between the ages of 17 and 30 have suffered fatal heart attacks, blood clots and possible strokes since August 2002. The first fatality publicly blamed on the Ortho Evra patch was in April 2005, when a Manhattan fashion student collapsed in a city subway station. An autopsy found that a blood clot had moved into the victim&#8217;s lung, and the medical examiner ruled that the clot was a side effect of the birth control device. Ortho-McNeil, the manufacturer or the Ortho Evra birth control patch, has aggressively marketed the patch as a convenient alternative to oral birth control pills. Its original product label stated that the patch&#8217;s health risks were similar to those related to oral contraceptives.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/ortho-evra-patch-litigation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Crestor Litigation</title>
		<link>http://www.bagoliefriedman.com/2011/09/crestor-litigation/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/crestor-litigation/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 18:51:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Product Liability]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=642</guid>
		<description><![CDATA[The use of Crestor has been linked to Rhabdomyolysis, a serious condition which may cause serious muscular problems and death. Over 104 million Americans have high or dangerously high cholesterol. High cholesterol places people at risk for heart attacks, heart &#8230; <a href="http://www.bagoliefriedman.com/2011/09/crestor-litigation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.bagoliefriedman.com/wp/wp-content/uploads/2011/09/crestor2.jpeg" alt="" title="" width="120" height="120" class="alignleft size-full wp-image-643" />The use of Crestor has been linked to Rhabdomyolysis, a serious condition which may cause serious muscular problems and death.</p>
<p>Over 104 million Americans have high or dangerously high cholesterol. High cholesterol places people at risk for heart attacks, heart disease, and strokes. Many people with elevated cholesterol seek the help of medical professionals to lower their cholesterol to a safe level, lessening the risk for serious health conditions. Healthy, low-fat eating, exercise, and cholesterol reducing medications are often part of the health regimen recommended by physicians to lower cholesterol. The following are recent cardiovascular disease (heart disease) statistics:</p>
<ul>
<li>Over 61 million people in the United States have some type of deadly cardiovascular disease.</li>
<li> More than 945,800 people died in the year 2000 from cardiovascular disease.  </li>
</ul>
<p>In August 2003, the U.S. Food and Drug Administration (FDA) approved the pharmaceutical drug Crestor, developed by the AstraZeneca company, to be made available to the public. The drug is a statin, which is a type of medication used to lower cholesterol. Since the drug was put on the market, many people have experienced serious and deadly side effects. A link between Crestor and Rhabdomyolysis has been discovered, and, as a result, the FDA has released a warning to all people who are currently or have previously taken the drug. </p>
<p>Rhabdomyolysis is a fatal condition that causes muscles to become weakened and break down, introducing muscle fibers into the circulatory system. Some symptoms of Rhabdomyolysis include:</p>
<ul>
<li>Abnormal weight gain</li>
<li>Dark urine</li>
<li>Exhaustion</li>
<li>Seizures</li>
<li>Sore muscles</li>
<li>Weak muscles</li>
</ul>
<p>After learning of the health risks involved with Crestor, the FDA recommended that the pharmaceutical drug be taken in smaller doses, although the risks are present at any dosage level. Some of the other very serious side effects of Crestor include kidney irregularities, kidney damage, and kidney failure.</p>
<p>As of July 2004, Crestor has been linked to two Rhabdomyolysis-related deaths, as well as seven cases of Rhabdomyolysis, four cases of acute renal failure, and five cases of kidney damage.</p>
<p>This is not the first time that a cholesterol lowering drug has caused death or serious physical injury. In 2001, Bayer Pharmaceutical Division decided to take Baycol, a cholesterol lowering drug, off the market because of its link to Rhabdomyolysis. The use of Baycol caused over 100 deaths and more than 480 cases of Rhabdomyolysis.</p>
<p>If you or a loved one are currently taking, or have taken, the prescription drug Crestor and have experienced any of the symptoms listed on this page, you may be at risk for serious, even fatal health problems. Please seek medical attention to find out if your use of Crestor has caused physical injury.</p>
<p>If you or a loved one is in need of legal assistance, call <strong>BAGOLIE FRIEDMAN, LLC</strong> toll free <strong>1-866-333-3LAW</strong> or <a href="contact-us">submit an online questionnaire</a>. The initial consultation is free of charge, and if we agree to handle your case, we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases, a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. Please call right away to ensure that you do not waive your right to possible compensation.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/crestor-litigation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Charite &amp; Artificial Spinal Disc Litigation</title>
		<link>http://www.bagoliefriedman.com/2011/09/charite-artificial-spinal-disc-litigation/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/charite-artificial-spinal-disc-litigation/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 18:24:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Product Liability]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=634</guid>
		<description><![CDATA[Johnson &#38; Johnson&#8217;s DePuy Spine Unit began selling Charite Artificial Spinal Discs in 2004. This product was supposed to reduce the need for spinal fusion and other serious spinal surgeries. However, the Charite artificial discs have been associated with life &#8230; <a href="http://www.bagoliefriedman.com/2011/09/charite-artificial-spinal-disc-litigation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.bagoliefriedman.com/wp/wp-content/uploads/2011/09/charitedisc1.jpg" alt="" title="" width="175" height="142" class="alignright size-full wp-image-635" />Johnson<br />
        &amp; Johnson&#8217;s DePuy Spine Unit began selling Charite Artificial Spinal Discs in 2004. This product was supposed to reduce the need for spinal fusion and other serious spinal surgeries. However, the Charite artificial discs have been associated with life threatening side effects which have made many surgeons reluctant to use the product. </p>
<p>In a recent report issued by TheStreet.com, Charles Rosen, a university-based spine surgeon said he can&#8217;t imagine using one now being promoted by Johnson &amp; Johnson. Rosen, recently filmed by PBS performing another new procedure, likes to provide his patients with cutting-edge services. </p>
<p>However, when Rosen learned more about the Charite discs he became alarmed. Rosen says he found that the devices have regularly failed in Europe, leaving patients with life-threatening complications. He says he finds it &quot;unbelievable&quot; that the Food and Drug Administration ever approved the devices. </p>
<p>&quot;Any prudent person, who does not have a financial conflict or industry tie, would reasonably conclude that their safety and effectiveness has not been proven by the FDA,&quot; says Rosen, an associate clinical professor of spine surgery at the University of California at Irvine. &quot;These artificial disc replacements should be recalled by the FDA to protect the American public.&quot; </p>
<p><img src="http://www.bagoliefriedman.com/wp/wp-content/uploads/2011/09/charitedisc2.jpg" alt="" title="" width="109" height="171" class="alignright size-full wp-image-636" />Not surprisingly, Johnson &amp; Johnson calls the implants as &quot;the best solution for the appropriate patients&quot; while stressing that &quot;patient selection is key.&quot; In any case, banning the implants could hurt Johnson &amp; Johnson and its competitors, who see the market as a lucrative growth opportunity. </p>
<p>To win over the FDA, Johnson &amp; Johnson set out to establish that Charite discs work at least as well as Bagby and Kuslich, or BAK, cages used in spinal fusions. But Rosen saw an immediate problem with the study design. &quot;The stand-alone BAK is a failed operation; it hasn&#8217;t been done in years,&quot; Rosen says. &quot;So they picked the worst possible operation to compare these things to.&quot; </p>
<p>Sarah Colamarino, a spokeswoman for the DePuy Spine unit of Johnson &amp; Johnson, says the BAK was &quot;the standard treatment for single-level degenerative disc disease&quot; at the time the study began. Regardless, Rosen claims the company still failed to prove its case. An FDA transcript shows that the agency&#8217;s own statistician portrayed the study as &quot;strongly biased&quot; in favor of Charite. The statistician also noted that the company had excluded important data about patients involved in the randomized clinical trials. </p>
<p>After years of research and development, Johnson &amp; Johnson (J&amp;J) was the first company to market an artificial spinal disk in the U.S. that would alleviate persistent back pain and permit natural body movement. Since marketing of the device know as Charite &cent; began, surgeons have been lining up at J&amp;J&#8217;s training center in Cincinnati to learn the implantation procedure. It is estimated that by 2010, the annual market for artificial disks could reach $1.7 billion. This particular device costs $11,500 with an additional $50,000 or more added on for the implantation surgery.</p>
<p>At this point, the last thing that J&amp;J needed was a debate about the durability of the device. Unfortunately for J&amp;J, that is precisely what it has on its hands. There are now surgeons who are predicting that, over the next 10 to 15 ears, there will be a wave of patients who will suffer applications and require surgical removal of the device. The surgeons consider this to be quite problematic because the removal procedure can be more dangerous than the surgery needed to repair a spinal fusion that has gone wrong. </p>
<p>Critics of the device have offered several reasons why they believe the rush to acceptance of the device is premature at best. These reasons include:</p>
<p>The 2-year trial used to win approval is far too short for a device that is expected to remain in the spine indefinitely without becoming displaced or causing other problems. </p>
<ul>
<li>The 304 patient trial group was too small. </li>
<li>In the trial, the device was compared with a standard fusion surgery which is now outdated. </li>
<li>Even when compared to that outdated version of spinal fusion, the device worked no better in relieving pain after 2 years. </li>
<li>Some insurance companies are refusing to cover the implantation procedure.   </li>
<li>There has been no showing by J&amp;J that the device will avoid the risks the company claims are inherent in fusion surgery. </li>
<li>The device is difficult to fix. </li>
<li>This device may not even be as good as others which are currently in clinical testing. </li>
<li>If this device is a failure it will give spinal arthroplasty a bad reputation.   </li>
<li>The device is really an alternative to spinal fusion rather than the superior procedure J&amp;J claims it to be. </li>
<li>Experts who have studied cases involving complications with the device found  many cases where everything was done right yet problems occurred. </li>
<li>The device promotes bad motion in the spine. </li>
<li>An analysis of several devices that were removed revealed wear that was similar to that in artificial hips and knees that generally last up to 10 years. While this might be acceptable in older patients, it is not for younger ones who would require additional life-threatening surgery to remove the device when it wears out.</li>
</ul>
<p>  The spinal column consists of 33 vertebrae that protect the spinal cord and provide stability to the torso. Between each vertebrae is a fibrous bundle of tissue called an intervertebral disc. This disc serves as a cushion to the spinal column by absorbing shock and pressure.</p>
<p>An intervertebral disc consists of two distinct regions:</p>
<ul>
<li>Outer region, or the annulus fibrosus &#8211; this retains the shape of the intervertebral disc.</li>
<li>Inner region, or the nucleus pulposus &#8211; this is soft, spongy tissue that gives the disc shock absorbing properties. </li>
</ul>
<p>As we age, the intervertebral discs degenerate and lose their ability to absorb shock. When water is lost in the disc, an injury or strain can cause the disc to tear or bulge. As the discs lose size and shock absorption abilities, the vertebrae come closer together and may compress spinal nerves. This often causes many types of disc pain that patients report such as pain, tingling and numbness.</p>
<p>The Charit&eacute; disc was intended for patients with degenerative discs between the lombar vertebrae L4 and L5 or between L5 and S1 (sacrum).</p>
<p>On October 20, 2005, the Bagolie Friedman law firm announced the formation of the &#8220;International Charite Artificial Disc Practice Group,&#8221; based on a belief that numerous people in the US and abroad, &#8220;suffer Charite artificial disc failure,&#8221; and that &#8220;Johnson and Johnson is responsible for manufacturing a medical device they knew or should have known was unreasonably dangerous in an attempt to capture some of the lucrative multi billion dollar back surgery market.&#8221; </p>
<p>&#8220;We will be reviewing potential cases from the United States, Australia and Europe,&#8221; said Mr Bagolie.</p>
<p>In 2003, DePuy Spine, a division of Johnson &#038; Johnson, acquired the Link Spine Group, and gained exclusive worldwide rights to the Charite. </p>
<p>In the paper, &#8220;Total Disc Replacement for Chronic Low Back Pain: Background and a Systematic Review of the Literature,&#8221; by M de Kleuver, F Oner, W Jacobs in the European Spine Journal Volume 12, Number 2, April 2003, the authors determined that despite the fact that these devices have been implanted for almost 15 years, on the basis of this literature survey there are currently insufficient data to assess the performance of total disc replacement adequately.</p>
<p>There is no evidence, the paper said, that disc replacement reliably, reproducibly, and over longer periods of time fulfils the three primary aims of clinical efficacy, continued motion, and few adjacent segment degenerative problems. </p>
<p>Total disc replacement, they said, seems to be associated with a high rate of re-operations, and the potential problems that may occur with longer follow-up have not been addressed. Therefore, the authors advised, total disc replacements should be considered experimental procedures and should only be used in strict clinical trials. J&#038;J beat out competitors Stryker and Medtronic by securing approval of the Charite, but many surgeons have criticized the FDA for approving the device and ignoring over 17 years of evidence related to its use Europe, including a study showing that more than half of recipients had fair or poor results.</p>
<p>The FDA approved the Charite based on the results of a single two-year clinical trial, that was designed to merely establish that the Charite disc worked at least as well as the Bagby and Kuslich cages (BAK) used in spinal fusions. The trial was conducted at the Texas Back Institute in Plano, Texas, on 304 patients, and was led by a team of surgeons that included Dr Scott Blumenthal, Dr Barton Sachs, and Dr Stephen Hochschuler, who are considered to be among the best spine surgeons in the field.</p>
<p> Dr Blumenthal presented the results of the trial at a hearing before an FDA advisory panel. A transcript of the June 2, 2004, hearing, reveals the agency&#8217;s own reviewer found the study to be biased in favor of Charite, and that important data about patients had been excluded. A voting member of the panel, Brent Blumenstein, complained about omitted patients during the hearing, but went on to vote for approval anyway.</p>
<p>Adverse events in the study, he explained, were categorized as typical or unusual, severe or life threatening, device related or not device related, severe and device related occurring within two days of surgery and by date of onset. A Danish surgeon, Dr Andre van Ooij, also testified at the hearing, and advised the panel about the known complications associated with the Charite, and provided the members with visual slides showing the adverse events that occurred in a number of patients. </p>
<p>Dr van Ooij tracked hundreds of surgeries in Europe and in eight years, he treated 49 Charite patients, 28 women and 28 men, with some their surgeries performed as early as 1989. All of these patients, he noted, suffered terrible leg and back pain after the device was implanted and many were unable to undergo a surgical revision of the disc due to the dangers involved in spinal surgery.</p>
<p>Dr van Ooij also advised that some men implanted with the device suffered retrograde ejaculation and erectile dysfunction, and others patients suffered leg complications and joint degeneration. &#8220;One big issue that was not spoken about today,&#8221; he pointed out, &#8220;is breakage of the metal wire.&#8221;</p>
<p>&#8220;If you look good at the x-rays,&#8221; he advised the panel while showing a slide, &#8220;you can see the breakage and the flattening of the polyethylene core and probably also some wear debris.&#8221; Overall, more than half of the patients in Europe ended up with fair or poor results after the disc was implanted.</p>
<p>Orthopedic and spine surgeon, John Peloza, also testified at the hearing and told the panel that first and foremost, the Charite disc had to last the lifetime of the patient and that the average age of a person that would be a candidate for the procedure is about the mid-40s. &#8220;I think it is critical that these implants last for the life of the patients,&#8221; he said, &#8220;because revision surgery to remove the implant particular from an anterior approach will be potentially life threatening in every case.&#8221; &#8220;And at present,&#8221; he advised, &#8220;there is no consistently successful strategy to deal with a failed implant.&#8221; &#8220;I don&#8217;t think the polyethylene as they have in this implant will last anywhere near 40 years or the lifetime of the patient,&#8221; he advised. In addition, he said the fixation of the disc to the bone was compromised.
</p>
<p>&#8220;The metal base is secured with a press fit with little spikes,&#8221; he explained. &#8220;This is not adequate and will predictably fail,&#8221; he added. There are published studies, he told the panel, that show significant re-operation rates between 5 and 20 percent with complication rates reported greater than 10 percent. As for results in regard to pain relief, the clinical studies in Europe and Australia, he said, essentially report results equivalent to fusion in regard to pain relief</p>
<p>The Charite does not absorb shock like a healthy disc or mimic natural motion, Dr Rosen told USA Today on July 25, 2006, and a dislocation or fracture of the disc can also cause problems, he said. In May 2006, Medicare decided to stop paying for the device in patients over 60, noting that the $30,000 to $50,000 surgery had not been sufficiently tested for long-term affects. Blue Cross and Blue Shield also determined that more research was needed over a longer period of time, although insurance plans in each state determine coverage decisions individually, according to USA Today.</p>
<hr />
<p>Have you or someone you love been injured by a Charite Artificial Disc? Trust Bagolie Friedman Injury Lawyers to fight for your rights and obtain the justice you deserve. We offer aggressive representation and free consultations. We are personal injury and workers&#8217; compensation trial lawyers.</p>
<p> Contact us now for a free, confidential and no risk consultation if you have questions about any type of accident, injury, disability, workers&#8217; compensation or disease claim. Whatever legal problem you have, our personal injury attorneys want to help.</p>
<p>This resource offers information on a wide variety of personal injury case types and is intended to help injury victims find the information they need to understand their legal rights and make informed decisions. If you would like to discuss a potential case please feel free to call toll free <strong>1-866-333-3LAW</strong> (1-866-333-3529)or submit a <a href="contact-us" target="_self">FREE<br />
online case review</a> .</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/charite-artificial-spinal-disc-litigation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cataract Implant Litigation</title>
		<link>http://www.bagoliefriedman.com/2011/09/cataract-implant-litigation/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/cataract-implant-litigation/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 18:06:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Product Liability]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=627</guid>
		<description><![CDATA[Hydroview or Aqua-sense intra-ocular lenses may be defective and cause unnecessary trauma. Lens implants (also known as intra-ocular lenses) are used in cataract surgery to replace the patient&#8217;s own lens. A packaging error is thought to be the blame for &#8230; <a href="http://www.bagoliefriedman.com/2011/09/cataract-implant-litigation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p>Hydroview or Aqua-sense intra-ocular lenses may be defective and cause unnecessary trauma. Lens implants (also known as intra-ocular lenses) are used in cataract surgery to replace the patient&#8217;s own lens.</p>
<p>A packaging error is thought to be the blame for the fault, which can cause cloudiness and poor vision.</p>
<p>Two specific brands are involved and are:</p>
<ul>
<li>Bausch and Lomb Hydroview H60M intraocular lens fitted between 1997 and 2001. </li>
<li>Opthalmic Innovations International Inc Aqua-sense fitted between December 1999 and 2000. Lens implants (also known as intra-ocular lenses) are used in cataract surgery to replace the patient&#8217;s own lens.</li>
</ul>
<p>Bagolie Friedman is investigating cataract implant claims world wide. If you or a loved one has experienced problems as a result of cataract implants, contact Bagolie Friedman now for a confidential and free consultation.</p>
<p class="head">Free Case Review!</p>
<p><a href="contact-us">Click here</a> for a free Cataract Implant Litigation case review.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/cataract-implant-litigation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>White Finger Syndrome</title>
		<link>http://www.bagoliefriedman.com/2011/09/white-finger-syndrome/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/white-finger-syndrome/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 17:52:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Workplace Injury]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=617</guid>
		<description><![CDATA[White Finger or Hand Arm Vibration Syndrome or Vibration White Finger is an industrial condition caused by exposure to hand transmitted vibration associated with the use of vibrating power tools. It can result in symptoms of discomfort, tingling, numbness and &#8230; <a href="http://www.bagoliefriedman.com/2011/09/white-finger-syndrome/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p><a href="white-finger-intake"><img src="http://www.bagoliefriedman.com/wp/wp-content/uploads/2011/09/whitefingerhand.jpg" alt="" title="" width="150" height="113" class="alignright size-full wp-image-618" /></a>White Finger or Hand Arm Vibration Syndrome or Vibration White Finger is an industrial condition caused by exposure to hand transmitted vibration associated with the use of vibrating power tools. It can result in symptoms of discomfort, tingling, numbness and whiteness in the fingers when exposed to the cold. By 1971 industry were or should have been aware of the dangers posed to workers by vibrating tools.</p>
<p>Exposure to significant vibration can give rise to symptoms of tingling in the hands and aching in the wrists and muscles of the forearm. Further symptoms of numbness and lack of sensitivity of the fingers can also occur. The greater and more frequent the exposure, the more severe will be the symptoms. Attacks of whiteness at the tips the fingers may occur when exposed to the cold which is caused by a restriction in the blood flow. When the blood supply returns, the hands and fingers can then go red and be accompanied by painful tingling which can last for up to an hour.</p>
<p>There is little effective treatment once vibration white finger vwf has developed. The body and hands should be kept warm which may help to maintain a good blood flow to the fingers and may reduce the risk of discomfort. Once damage to the nerves or nerve fibres has occurred there is no means of repair.</p>
<p><img src="http://www.bagoliefriedman.com/wp/wp-content/uploads/2011/09/whitefingersaw.jpg" alt="" title="" width="150" height="113" class="alignright size-full wp-image-619" />Tools likely to cause vibration injury include:</p>
<ul>
<li>Percussive tools e.g. riveting, caulking, fettling and swaging</li>
<li> Grinders including pedestal and hand-held grinders</li>
<li>Pneumatic drills and hammers, including percussive and rotary hammers</li>
<li>Chain saws and other garden machinery</li>
</ul>
<p> Industrial diseases affect thousands of people every year and the consequences can be devastating both to work and family life. Our team of attorneys have experience in dealing with White Finger claims. </p>
<p class="head">Free Case Review!</p>
<p><a href="contact-us">Click here</a> for a free White Finger case review.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/white-finger-syndrome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Welding Rod Litigation</title>
		<link>http://www.bagoliefriedman.com/2011/09/welding-rod-litigation/</link>
		<comments>http://www.bagoliefriedman.com/2011/09/welding-rod-litigation/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 17:45:47 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Workplace Injury]]></category>

		<guid isPermaLink="false">http://www.bagoliefriedman.com/wp/?p=612</guid>
		<description><![CDATA[A recent study conducted by researchers at Washington University at St. Louis suggests that industrial exposure to welding fumes may be associated with the early onset of Parkinson&#8217;s disease. Welding rods, electrodes and wire contain numerous substances including manganese, copper, &#8230; <a href="http://www.bagoliefriedman.com/2011/09/welding-rod-litigation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.bagoliefriedman.com/wp/wp-content/uploads/2011/09/welding.jpg" alt="" title="" width="143" height="177" class="alignright size-full wp-image-613" />A recent study conducted by researchers at Washington University at St. Louis suggests that industrial exposure to welding fumes may be associated with the early onset of Parkinson&#8217;s disease. Welding rods, electrodes and wire contain numerous substances including manganese, copper, lead and cadmium, that release toxic fumes when used during welding. New evidence suggests that chronic exposure to welding fumes may cause a host of symptoms linked to or similar to Parkinson&#8217;s disease. Symptoms of such a condition include; tremors, rigidity, abnormal or shuffling gait, lack of arm swing and loss of balance. If the conclusions drawn by these new studies can be substantiated, claims might be made against the manufacturers of welding rods, electrodes, and wire. </p>
<p> <strong>Welders and former welders! </strong> If you are currently suffering from symptoms related to Parkinsons Disease, you may have a claim.</p>
<p> We are currently investigating potential claims against the manufacturers of welding products, including welding rods, wires and electrodes, for damages caused by exposure to manganese fumes. This potentially harmful exposure usually occurs during the process of steel-alloy welding and other steel melting activities.</p>
<p> The process of heating or cutting steel can cause the release of manganese fumes. These fumes, if inhaled, can cause neurological damage. Prolonged exposure to these fumes can cause a condition called manganism, a disorder very similar to Parkinson&#8217;s disease. In fact, recently, exposure to manganese fumes due to welding has been associated with the early onset of Parkinson&#8217;s disease. The symptoms of manganism and Parkinson&#8217;s disease include: fatigue, headache, muscle cramps, loss of appetite, apathy, insomnia, feelings of weakness and lethargy, speech disturbances, a mask-like face, tremors, disorientation, loss of memory, impairment of judgment, anxiety, hallucinations, illusions, delusions, abnormal gait, and loss of the ability to control muscular movement.</p>
<p> The following activities can cause exposure to manganese fumes: gas metal arc or metal inert gas (MIG) welding, gas tungsten arc or tungsten inert gas (TIG) welding, flux cored arc welding, shielded metal arc welding, brazing, thermal cutting, metal pouring or gauging. If you performed welding-related activities, or worked for extended periods of time in areas where such activities were conducted, you may have been exposed to manganese fumes.</p>
<p> If you were involved in any of these welding or welding-related activities OR worked for extended periods of time in areas where such activities were conducted, AND now EITHER are suffering from Manganism, manganese induced Parkinsonism or Parkinson&#8217;s disease, OR are suffering from any of the symptoms listed above, and you are interested in us evaluating your condition, please click here to fill out a questionnaire. The information you provide will enable us to determine the viability of any potential claim you may have.</p>
<p class="subhead"> Below is a list of manufacturers whose welding rods you may have used:</p>
<ul>
<li> Air Products Linde Stoody</li>
<li> Airco Manquette Tri-Mark</li>
<li> Ancos McKay Co. Unibraze</li>
<li> Alloy Rods Mid States Victon</li>
<li> Amsco Murex Wall Company</li>
<li> Coast Metals National Standard Westinghouse</li>
<li> Enterprise Paje </li>
<li> Haynes Stellite Rankin </li>
<li> Hobart Reid-Avery Co. </li>
<li> Lincoln Electric Rexanc </li>
</ul>
<p>We urge you to act quickly as any claim you may have is subject to a statute of limitations. If you do not file a lawsuit prior to the expiration of the statute of limitations, you will be forever prevented from pursuing a claim. Your statute of limitations may have already expired and, if it has not, each day that passes brings you closer to the expiration of the statute of limitations. Contact Bagolie Friedman, toll free, at 1-866-333-3529 now for a confidential and free case evaluation.</p>
<p class="subhead">The Problem</p>
<p>The use of welding products and equipment in the welding process causes emission of fumes. Many, if not most, of these fumes contain manganese. A small amount of manganese is necessary for the human body to remain healthy. However, too much manganese can cause serious medical problems. Since 1837, manganese has been medically recognized as toxic to the brain and central nervous system when the levels in the body exceed normal limits. The toxicity of manganese causes a progressive condition, referred to as Manganism (also known as manganese poisoning, maganese-induced parkinsonism, and manganese intoxication). Manganism, a form of parkinsonism, manifests itself through various neurological symptoms which can be seriously disabling. People exposed to welding fumes absorb manganese into their body primarily through inhalation of the fumes. This occurs primarily when welders are working in confined spaces without proper ventilation. Inhalation of welding fumes over an extended period of time can lead to Manganism.</p>
<p class="subhead">The Connection</p>
<p>It has been recognized for almost two centuries that there is a causal connection between welding fumes that contain manganese and neurological injuries. In fact, documentation of these injuries dates back to 1837. In 1837, a published paper described two ore workers who experienced manganese poisoning. These workers were suffering from fixed gaze, slow movements, rigidity, tremor, along with other neurological symptoms. In 1932, a medical article described how manganese electrodes should be avoided and that manganese fumes were a health risk for the welder. In 1937, an insurance company published a welding safety booklet stating that manganese in welding fumes &#8220;causes a disease similar to paralysis agitans [Parkinson&#8217;s disease]. In 1963, a toxicologist by the name of Dr. Irving Sax published a book which noted that manganese &#8220;affects the nervous system and can cause paralysis to a degree which may be disabling&#8221; and that &#8220;widespread&#8230;exposure occurs in electric arc welding since most welding rod coatings contain manganese.&#8221; In 1981, the World Health Organization recognized that &#8220;Chronic manganese poisoning is a hazard in&#8230;welding.&#8221; In recent years, several articles have described the link between parkinsonism and welders. According to Dr. Abe Lieberman, manganese is probably responsible for more cases of parkinsonism than any other toxin. An article published in 2001 notes that the pathophysiology of welding-related parkinsonism is similar to idiopathic Parkinson&#8217;s Disease. This study found that on average, welders developed parkinsonism 15 years earlier than the general population. </p>
<p class="subhead">The Difference Between Manganism And Parkinson&#8217;s</p>
<p>Parkinsonism is generally thought to be a group of neurological disorders characterized by hypokinesia (decreased muscular activity), tremor, and muscular rigidity. This group of disorders includes Parkinson&#8217;s Disease and Manganism, but these are distinct medical conditions. While Parkinson&#8217;s Disease has no known cause, Manganism is caused by overexposure to manganese. There is some tension in the medical literature whether there are differences in the symptoms caused by manganese-induced parkinsonism and idiopathic Parkinson&#8217;s Disease. For example, some medical professionals make a distinction between the two conditions based on the clinical presentation. One distinction between the two forms is that patients with Parkinson&#8217;s Disease often experience a resting tremor where patients with Manganism often experience an intention tremor. However, because the symptoms are so similar, some patients may be diagnosed with Parkinson&#8217;s Disease when they actually suffer from manganese poisoning. Since there are no blood tests which can distinguish between the two, these diseases are usually diagnosed on symptoms and pertinent medial history. While it is possible to measure the amount of manganese in the blood, many patients are seen by the doctor after the manganese exposure has ended and blood levels of manganese have returned to normal. While the symptoms of Manganism and Parkinson&#8217;s Disease may be similar, there are distinct differences in the regions of the brain which are affected in these conditions. Manganese toxicity is thought primarily to affect two regions of the basal ganglia, including the striatum and globus palladus. On the other hand, idiopathic Parkinson&#8217;s Disease is thought to affect primarily the substantial nigra by reducing dopamine levels. Sinemet, a common medication used for Parkinson&#8217;s Disease, acts to replace the dopamine in this region and this medication can favorably affect a patient who has idiopathic Parkinson&#8217;s Disease. Due to the different regions of the brain affected in Mangansim, there is often no beneficial effect of dopamine replacement therapy in patients who suffer from this form of parkinsonism. There appear to be three stages in the development of Mangansim. The first stage includes symptoms of malaise, apathy, emotional instability, sexual dysfunction, weakness, lethargy, loss of appetite, and headaches. The second stage progresses to include more psychological disturbances, such as impaired memory and judgment, anxiety,<br />
  and possible hallucinations. Finally, the third stage of manganese poisoning includes symptoms such as progressive bradykinesia, impairment of voluntary movements, gait disturbances, rigidity, tremors, impaired coordination, and mask-like features. Early Mangansim may be reversible upon withdrawal of manganese exposure; however, neurological damage by the third stage of symptoms is reported to be permanent and progressive. People who are affected by manganese poisoning may be permanently and completely disabled. </p>
<p class="subhead">How The Welding Industry Has Tried To Hide The Risk</p>
<p>Beginning in the late 1970s and early 1980s, lawsuits against companies in the welding industry began appearing. These lawsuits brought claims against not only the manufacturers of welding rods, but also against some of the welding industry&#8217;s trade organizations. What follows is a description of the allegations made in that litigation. These allegations have not been proven as fact at this time.The American Welding Society (AWS) is a trade organization that includes within its membership management representatives of companies that manufacture and sell welding products, and large consumers that buy the products for use in their operation. Another large trade organization from the welding industry is the National Electrical Manufacturer&#8217;s Association (NEMA) which includes welding rod manufacturers as members. These two organizations created several committees, composed of representatives from manufacturers within in the welding industry. These committees, among other things, made decisions on how to disseminate information to the public about the potential hazards of welding fumes. As early as the 1930&#8242;s, it has been alleged that members of the welding industry agreed to conceal known hazards associated with welding fumes by forming a committee to preempt investigation of welding fume hazards by independent sources that were not controlled by the industry. The members of the industry agreed to undertake an investigation of the health hazards of welding fumes. However, upon completion of this investigation, they changed the conclusions of the study to represent that welding fumes were not harmful to welders. In the 1940&#8242;s, members of NEMA&#8217;s Arc Welding Section agreed to publish a two-part article which made the representation that welding fumes were not toxic. Additionally, the members of the industry rejected the adoption of any precautionary product labels for welding products. One possible motivation for this decision was an industry fear that welders would be afraid to use welding products if they were to see such precautionary product labels, and thus sales of welding products would be reduced. In the 1950&#8242;s, the industry adopted a policy of refuting existing reports of welding fume hazards by publishing their own reports which represented exposure to welding fumes as safe. It was agreed to sponsor the publication of an article in a trade publication which made the representation that &#8220;toxic gases are not produced by electrode coatings.&#8221; However, in contrast with the publication, the AWS issued a technical document reflecting its knowledge that manganese in welding fumes is a potentially toxic substance. By the 1970&#8242;s, the industry was well aware that welding fumes could cause neurological damage due to manganese poisoning. A study found that welding fumes could easily exceed the recommended occupational exposure guidelines, even when ventilation standards specified by welding rods manufacturers were followed. The industry was also aware that manganese poisoning from welding fumes could be misdiagnosed as idiopathic Parkinson&#8217;s Disease, and that the problem was so widespread as to require an epidemiological study. While the committee voted to undertake this epidemiological study, it was never completed. Finally, in 1985, some of the welding rod manufacturers state in their Manufacturer Safety Data Sheets (MSDS), which are technical documents of limited distribution, that manganese in welding fumes could cause neurological damage and requires quarterly medical examinations. </p>
<p class="subhead">What Does All This Mean And What Can I Do Now?</p>
<p>Bagolie Friedman is representing welders and we have come to one conclusion: that the welding rod manufacturers and trade associations have a responsibility to ensure the health, safety and welfare of the workers they put in harms way. You may also be covered under your State&#8217;s Workers&#8217; Compensation system. </p>
<p class="head">Free Case Review!</p>
<p><a href="contact-us">Click here</a> for a free Welding Rod case review.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.bagoliefriedman.com/2011/09/welding-rod-litigation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

